摘要
HBV是肝细胞癌(hepatocellular carcinoma, HCC)最重要的危险因素,而HBV再激活很可能加快HCC的发生发展。了解HBV再激活的影响因素对HCC的治疗和预后有重要意义。本文对HCC不同治疗方案对HBV再激活的影响展开综述。
HBV is the most important risk factor for patients with hepatocellular carcinoma, and its reactivation is bound to accelerate the occurrence and development of HCC, thus understanding the influencing factors of HBV reactivation is of great value in the treatment and prognosis of HCC. This article reviews the effect of HBV reactivation on HCC patients after different regimens.
作者
雷进
韩明娟
左石
陈博文
张林枝
贾晓东
肖本立
Rifaat Safadi
陆荫英
LEI Jin;HAN Ming-juan;ZUO Shi;CHEN Bo-wen;ZHANG Lin-zhi;JIA Xiao-dong;XIAO Ben-li;Rifaat Safadi;LU Yin-ying(Class 2,Master of 2020,School of Clinical Medicine,Guizhou Medical University,Guiyang 550001,China)
出处
《传染病信息》
2022年第4期361-365,共5页
Infectious Disease Information
基金
深圳市科技创新委员会可持续发展专项(2019N002)
国家自然科学基金青年项目(81902495)。
关键词
乙型肝炎病毒
慢性乙型肝炎
HBV再激活
HCC
治疗方式
危险因素
抗病毒治疗
hepatitis B virus
chronic hepatitis B
hepatitis B reactivation
hepatocellular carcinoma
treatment mode
risk factor
antiviral treatmentl
